PUBLISHER: The Business Research Company | PRODUCT CODE: 1945530
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945530
Medical device affairs outsourcing involves contracting external specialists to manage regulatory compliance and quality assurance for medical devices, helping companies meet complex global standards more efficiently.
The primary services in medical device affairs outsourcing include regulatory writing and submissions, regulatory registration services, regulatory consulting, and others. Regulatory writing and submission services involve preparing and filing documentation required by regulatory authorities to obtain approvals for medical devices. The software solutions include cloud-based platforms and on-premise systems, and these services are used by end users such as pharmaceutical companies, medical technology firms, and others.
Tariffs have influenced the medical device affairs outsourcing market by increasing costs for imported software platforms and consulting services used for regulatory compliance. Segments such as cloud-based software solutions and regulatory consulting are most affected, particularly in regions like Asia-Pacific and Europe where outsourcing hubs rely on imported technology and expertise. While tariffs have created cost pressures and operational adjustments, they also encourage local development of regulatory tools and services, fostering innovation and domestic capacity building.
The medical device affairs outsourcing market research report is one of a series of new reports from The Business Research Company that provides medical device affairs outsourcing market statistics, including medical device affairs outsourcing industry global market size, regional shares, competitors with a medical device affairs outsourcing market share, detailed medical device affairs outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device affairs outsourcing industry. This medical device affairs outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical device affairs outsourcing market size has grown strongly in recent years. It will grow from $5.45 billion in 2025 to $5.85 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing regulatory complexities, reliance on in-house regulatory teams, growing number of medical device approvals, expansion of global medical device markets, rising awareness of compliance risks.
The medical device affairs outsourcing market size is expected to see strong growth in the next few years. It will grow to $7.65 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to adoption of advanced regulatory software solutions, growth in outsourcing partnerships, increasing focus on strategic regulatory planning, expansion of post-market surveillance programs, integration of ai and analytics for regulatory efficiency. Major trends in the forecast period include increasing adoption of regulatory affairs outsourcing by medical device companies, rising demand for cloud-based compliance and management solutions, focus on streamlining clinical trial applications and regulatory submissions, growth in quality management system (qms) support services, enhanced post-market surveillance and risk assessment capabilities.
The increasing demand for medical devices is increasingly supporting the expansion of the medical device affairs outsourcing market going forward. Medical devices include instruments, machines, implants, and apparatuses used to diagnose, treat, or prevent medical conditions. Demand for medical devices continues to rise due to improved treatment outcomes, enhanced patient care, and expansion of healthcare infrastructure. Medical device affairs outsourcing supports manufacturers by improving regulatory compliance, streamlining operations, and accelerating market access, enabling companies to focus on innovation and core competencies. For example, in April 2024, according to the Medicines and Healthcare products Regulatory Agency, a UK-based government agency, the number of registered medical products increased from approximately 2.25 million in 2022 to around 3.25 million in 2024. As a result, the growing demand for medical devices is reinforcing expansion across the medical device affairs outsourcing market.
Leading companies operating in the medical device affairs outsourcing market are strengthening decentralized clinical trial capabilities to improve research efficiency, patient recruitment, and data quality. Decentralized clinical trials use digital tools and remote participation to enhance flexibility and accessibility while maintaining regulatory compliance. For example, in March 2023, Syneos Health, a US-based provider of contract research and commercialization services, launched a Decentralized Clinical Trial Site Network to support broader adoption of decentralized trial models. This initiative enhances trial quality, patient engagement, and evidence generation for medical device commercialization.
In June 2023, Arterex Medical, a US-based provider of medical device contract manufacturing services, acquired NextPhase Medical Devices LLC for an undisclosed amount. With this acquisition, Arterex enhances its manufacturing capabilities and positions itself for future growth in a competitive market environment. NextPhase Medical Devices LLC is a US-based company that offers medical device regulatory and quality affairs outsourcing services.
Major companies operating in the medical device affairs outsourcing market are IQVIA Holdings Inc, ICON PLC, PAREXEL International Corporation, Intertek Group PLC, Eurofins Scientific SE, SGS SA, TUV SUD AG, TUV Rheinland AG, UL Solutions Inc, BSI Group, RQM Plus LLC, NAMSA, Medpace Holdings Inc, WuXi AppTec Inc, Charles River Laboratories International Inc, Laboratory Corporation of America Holdings, Sterigenics International LLC, Pace Analytical Services LLC, Avania LLC, Qserve Group BV, IMed Consultancy Ltd, Global Regulatory Partners Inc, MedTech Review LLC, Clario Inc, ProPharma Group Inc, NSF Health Sciences LLC
Europe was the largest region in the medical device affairs outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device affairs outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical device affairs outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The medical device affairs outsourcing includes revenues earned by entities by providing services such as data management services, compliance management, and documentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Device Affairs Outsourcing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical device affairs outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical device affairs outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device affairs outsourcing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.